Gurdon, 2016 - Google Patents
Nuclear reprogramming and cell replacement therapiesGurdon, 2016
- Document ID
- 6495754363238145766
- Author
- Gurdon J
- Publication year
- Publication venue
- Nature Reviews. Molecular Cell Biology
External Links
Snippet
This issue of Nature Reviews Molecular Cell Biology celebrates the 10th anniversary of the pioneering 2006 publication reporting the derivation of induced pluripotent stem cells. Earlier work that led in this direction included nuclear transfer experiments in Amphibia and …
- 238000009256 replacement therapy 0 title abstract description 5
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fronk et al. | Methods for culturing retinal pigment epithelial cells: a review of current protocols and future recommendations | |
| Chen et al. | The simulated microgravity enhances the differentiation of mesenchymal stem cells into neurons | |
| Shroff et al. | Therapeutic potential of human embryonic stem cell transplantation in patients with cerebral palsy | |
| Al-Zer et al. | Dental pulp stem cells-derived schwann cells for peripheral nerve injury regeneration | |
| CN106619722A (en) | Neural stem cell injection for treating brain damage disease | |
| Ling et al. | Pretreatment of rat bone marrow mesenchymal stem cells with a combination of hypergravity and 5‐azacytidine enhances therapeutic efficacy for myocardial infarction | |
| Pandamooz et al. | The influence of cerebrospinal fluid on epidermal neural crest stem cells may pave the path for cell-based therapy | |
| Dong et al. | Stem cell and peripheral nerve injury and repair | |
| CN107354127A (en) | Effects of the LncRNA TUG1 in regulation and control PDLSCs Osteoblast Differentiations and regeneration | |
| Taylor et al. | Hypoxic preconditioning of myoblasts implanted in a tissue engineering chamber significantly increases local angiogenesis via upregulation of myoblast vascular endothelial growth factor‐A expression and downregulation of miRNA‐1, miRNA‐206 and angiopoietin‐1 | |
| CN106244548B (en) | Purposes of the luteolin in inducing mesenchymal stem cell into the differentiation of neural cell directional | |
| Gurdon | Nuclear reprogramming and cell replacement therapies | |
| Tao et al. | A bibliometric analysis of the application of stem cells in glaucoma research from 1999 to 2022 | |
| Gage | Transplantation in the future | |
| CN106282113A (en) | A kind of method utilizing serum-free medium to pass through transdifferentiation acquisition neurocyte | |
| Wu et al. | Retinal cell fate specification | |
| Zhang et al. | Therapeutic effects of dental pulp stem cells on vascular dementia in rat models | |
| Goergen et al. | Characterization of Bone‐Marrow‐Derived Stem Cells in Osteoporotic Models of the Rat | |
| CN106350490B (en) | The method of nerve cell is obtained from fibroblast using serum free medium | |
| Finocchio et al. | Recent advances of adipose-tissue-derived mesenchymal stem cell-based therapy for retinal diseases | |
| Häfner | The body's integrated repair kit: Studying mesenchymal stem cells for better ligament repair | |
| Mastrolia et al. | Autologous marrow mesenchymal stem cell driving bone regeneration in a rabbit model of femoral Head Osteonecrosis | |
| Loo et al. | Comparative analysis of cardiovascular development related genes in stem cells isolated from deciduous pulp and adipose tissue | |
| Nikitina et al. | Risk of genetic transformation of multipotent mesenchymal stromal cells in vitro | |
| Laplane | Reprogramming and stemness |